Overview

Update
IPO / Stock
Went Public on Jul 24, 2014 / NASDAQ:XENT
Total Equity Funding
$79.33M in 3 Rounds from 6 Investors
Headquarters:
Menlo Park, CA
Description:
Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.
Founders:
Categories:
Pharmaceutical, Health Care, Medical
Website:
http://www.intersectent.com

Funding Rounds (3) - $79.33M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2013$18.31M / Venture0
Feb, 2013$30M / Series D5
Oct, 2010$31.02M / Venture5

Current Team (8)

Update

Offices/Locations (1)

Update
  • HQ

    1555 Adams Drive

    Menlo Park, CA 94025

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos